Journal article

From epidemic meningitis vaccines for Africa to the Meningitis Vaccine Project

In June 2001, BMGF awarded a grant of US$70 million to create the Meningitis Vaccine Project (MVP) as a partnership between PATH and WHO, with the specific goal of developing an affordable MenA conjugate vaccine to eliminate MenA meningitis epidemics in Africa. EVA is an example of the use of WHO as an important convening instrument to facilitate new approaches to address major public health problems.

Languages

  • English

Publication year

2015

Journal

Clin Infect Dis.

Volume

Suppl. 5

Type

Journal article

Categories

  • Global initiatives

Countries

  • Benin
  • Burkina Faso
  • Burundi
  • Cameroon
  • Central African Republic
  • Chad
  • Cote D'Ivoire
  • Democratic Republic Of The Congo
  • Eritrea
  • Ethiopia
  • Ghana
  • Guinea
  • Guinea Bissau
  • Kenya
  • Mali
  • Mauritania
  • Niger
  • Nigeria
  • Rwanda
  • Senegal
  • South Sudan
  • Togo
  • Uganda

WHO Regions

  • African Region

Added by: Moderator

Added on: 2022-09-20 09:38:18

Hits: 2235